Showing results (2351-2360 of 13,176) with videos related to
Sort By:
Pageof 1,318
Diabetes Care|May 3, 2013
Chronotype is independently associated with glycemic control in type 2 diabetesSirimon Reutrakul, Megan M Hood, Stephanie J Crowley, et al.Diabetes Care|April 13, 2013
Mechanisms of glucose lowering of dipeptidyl peptidase-4 inhibitor sitagliptin when used alone or with metformin in type 2 diabetes: a double-tracer studyCarolina Solis-Herrera, Curtis Triplitt, Jose de Jesús Garduno-Garcia, et al.Diabetes Care|April 13, 2013
Independent and combined association of muscle strength and cardiorespiratory fitness in youth with insulin resistance and β-cell function in young adulthood: the European Youth Heart StudyAnders Grøntved, Mathias Ried-Larsen, Ulf Ekelund, et al.Diabetes Care|February 14, 2013
Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseasesChanshin Park, Eliseo Guallar, John A Linton, et al.Diabetes Care|February 14, 2013
Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engineShiro Tanaka, Sachiko Tanaka, Satoshi Iimuro, et al.Diabetes Care|February 16, 2013
Determinants of weight gain in the action to control cardiovascular risk in diabetes trialVivian Fonseca, Roberta McDuffie, Jorge Calles, et al.Diabetes Care|February 16, 2013
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled studyDavid Polidori, Sue Sha, Sunder Mudaliar, et al.Diabetes Care|February 21, 2013
Mercury exposure in young adulthood and incidence of diabetes later in life: the CARDIA Trace Element StudyKa He, Pengcheng Xun, Kiang Liu, et al.Diabetes Care|March 8, 2013
Economic costs of diabetes in the U.S. in 2012Diabetes Care|March 12, 2013
Changes in insulin resistance and HbA1c are related to exercise-mediated changes in body composition in older adults with type 2 diabetes: interim outcomes from the GREAT2DO trialYorgi Mavros, Shelley Kay, Kylie A Anderberg, et al.Pageof 1,318